Validation of the Prognostic Performance of Breast Cancer Index in Hormone Receptor-Positive Postmenopausal Breast Cancer Patients in the TEAM Trial.
Timothy J WhelanKeying XuJenna WongGregory Russell PondYi ZhangMelanie SpearsRanelle SalungaElizabeth MallonKaren J TaylorAnnette HasenburgMarkopoulos ChristosLuc DirixCornelis J H van de VeldeDaniel W ReaCatherine A SchnabelKai TreunerJane BayaniPublished in: Clinical cancer research : an official journal of the American Association for Cancer Research (2024)
The TEAM trial represents the largest prognostic validation study for BCI to date and provides a more representative assessment of late DR risk to guide individualized treatment decision-making for HR+ patients with early-stage breast cancer.